EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Failure of serotonin antagonist pizotifen to stimulate feeding or weight gain in free-feeding rats



Failure of serotonin antagonist pizotifen to stimulate feeding or weight gain in free-feeding rats



Pharmacology, Biochemistry, and Behavior 35(1): 61-67



The serotonin antagonist pizotifen (BC-105) is prescribed as an appetite and weight enhancer (Mosegor--Wander, also commercialized under brand names Sanmigran or Sandomigran--Sandoz, Switzerland) for anorectic and convalescent humans. There has been, however, difficulty in demonstrating any orexigenic effect of pizotifen in laboratory animals. In the present report, the influence of chronic administration of pizotifen (0.1-30.0 mg/kg b.wt. per day, SC) on food intake and body weight gains was studied in rats given a standard diet (SD-energy content 14.5 kJ/g, 9% fibre), and in rats either habituated to a low energy content, carbohydrate-free diet (DD-7.3 kJ/g, 45% fibre), or given the DD after habituation to the SD. Pizotifen failed to increase food intake or weight gain. Nor did it shorten a period of initial depression of intake of the unfamiliar DD. On the contrary, pizotifen seemed to diminish food intake and weight gain in rats fed the low energy content diet. Since it has been reported that other 5-HT antagonists, e.g., cyproheptadine, methysergide, and ritanserin can enhance feeding, it is of some interest that pizotifen failed to affect food intake or weight gain in rats. The results suggest that the effects of pizotifen (and, possibly, of serotonin) in rats may differ from those in man. The possibility that feeding in the rat is mediated by 5-HT1 rather than 5-HT2 receptors is discussed.

(PDF emailed within 0-6 h: $19.90)

Accession: 040125504

Download citation: RISBibTeXText

PMID: 2315371

DOI: 10.1016/0091-3057(90)90205-v



Related references

Failure of pizotifen (BC-105) to stimulate appetite in rats. Annals of the New York Academy of Sciences75(575): 578-579, 1989

Genetic relationships between weight gain and feeding behaviour of ad libitum-fed pigs and weight gain of heavy pigs under restricted feeding. Italian Journal of Animal Science 4(Suppl. 2): 79-81, 2005

The long-term effects of feeding honey compared with sucrose and a sugar-free diet on weight gain, lipid profiles, and DEXA measurements in rats. Journal of Food Science 73(1): H1-H7, 2008

Effects of a beta antagonist propranolol and a serotonin antagonist cyproheptadine on feeding in rats injected with noradrenaline. Animal Science & Technology 62(9): 849-853, 1991

Effects of serotonin antagonist, cyproheptadine, and serotonin depletor, p-chlorophenylalanine, on feeding in rats kept at high and temperate-ambient temperatures. Animal Science & Technology 66(7): 594-598, 1995

Central infusion of interleukin-1 receptor antagonist fails to alter feeding and weight gain. Neuroreport 11(8): 1699-1702, 2000

Selection for weight gain in mice at two ages and under ad libitum and restricted feeding. I. Direct and correlated responses in weight gain and body weight. Theoretical and Applied Genetics 75(3): 415-423, 1988

Weight cycling induced by AD-LIB and restricted feeding of a high fat diet did not enhance rate of weight gain in rats. FASEB Journal 8(4-5): A170, 1994

The effect of additional feeding of piglets on weight gain the after weaning using different feeding methods. 9 Tagung Schweine und Geflugelernahrung, Martin Luther Universitat Halle Wittenberg, Halle, Germany, 28-30 November 2006: 43-46, 2006

A responsive feeding intervention increases children's self-feeding and maternal responsiveness but not weight gain. Journal of Nutrition 139(9): 1738-1743, 2009

Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice. Bioorganic & Medicinal Chemistry Letters 19(3): 639-643, 2010

Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body weight gain in mice. 2009

Effect of force feeding on weight and subsequent food intake of weight gain recovered area postrema lesioned rats. Society for Neuroscience Abstracts 13(1): 466, 1987

Failure of a premature infant to gain weight due to a low-sodium feeding: report of case. Proceedings of the Staff Meetings. Mayo Clinic 29(3): 90-96, 1954